IMRN

#5142
Immuron Limited American Depositary Shares
0.77
-8.33%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
0.77
0.77
Intervallo Annuale
0.68
2.38
Variazione giornaliera
-8.33%
Variazione Mensile
-20.62%
Variazione di 6 mesi
-56.25%
Variazione Annuale
-59.90%
Chiusura Precedente
0.84
Open
0.77
Bid
Ask
Low
0.77
High
0.77
Volume
1
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

Immuron Limited - American Depositary Shares

Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited. Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment. In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market.

Notizie